These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 31692740)

  • 1. Hemolytic anemia caused by non-D minor blood incompatibilities in a newborn.
    Tugcu AU; Ince DA; Turan O; Belen B; Olcay L; Ecevit A
    Pan Afr Med J; 2019; 33():262. PubMed ID: 31692740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemolytic Anemia and Heart Failure Caused by Anti-C and Anti-E Immunization.
    Bilgin H; Eren A; Kara S
    J Coll Physicians Surg Pak; 2016 Jun; 26(6):539-40. PubMed ID: 27353998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemolytic disease of the newborn due to isoimmunization with anti-E antibodies: a case report.
    Sarici SU; Alpay F; Yeşilkaya E; Ozcan O; Gökçay E
    Turk J Pediatr; 2002; 44(3):248-50. PubMed ID: 12405439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe neonatal hyperbilirubinemia secondary to combined RhC hemolytic disease, congenital hypothyroidism and large adrenal hematoma: a case report.
    Dai C; Chen C; Jiang L; Zhu Y; Wang C
    BMC Pediatr; 2022 Sep; 22(1):539. PubMed ID: 36089589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemolytic disease of the newborn caused by irregular blood subgroup (Kell, C, c, E, and e) incompatibilities: report of 106 cases at a tertiary-care centre.
    Karagol BS; Zenciroglu A; Okumus N; Karadag N; Dursun A; Hakan N
    Am J Perinatol; 2012 Jun; 29(6):449-54. PubMed ID: 22399212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sn-Mesoporphyrin interdiction of severe hyperbilirubinemia in Jehovah's Witness newborns as an alternative to exchange transfusion.
    Kappas A; Drummond GS; Munson DP; Marshall JR
    Pediatrics; 2001 Dec; 108(6):1374-7. PubMed ID: 11731664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An early (sixth-hour) serum bilirubin measurement is useful in predicting the development of significant hyperbilirubinemia and severe ABO hemolytic disease in a selective high-risk population of newborns with ABO incompatibility.
    Sarici SU; Yurdakök M; Serdar MA; Oran O; Erdem G; Tekinalp G; Yiğit S
    Pediatrics; 2002 Apr; 109(4):e53. PubMed ID: 11927726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of the development of neonatal hyperbilirubinemia in ABO incompatibility.
    Chen JY; Ling UP
    Zhonghua Yi Xue Za Zhi (Taipei); 1994 Jan; 53(1):13-8. PubMed ID: 8173995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous immunoglobulin G (IVIG) therapy for significant hyperbilirubinemia in ABO hemolytic disease of the newborn.
    Miqdad AM; Abdelbasit OB; Shaheed MM; Seidahmed MZ; Abomelha AM; Arcala OP
    J Matern Fetal Neonatal Med; 2004 Sep; 16(3):163-6. PubMed ID: 15590442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous immunoglobulin in the management of hemolytic disease of the newborn.
    Mundy CA
    Neonatal Netw; 2005; 24(6):17-24. PubMed ID: 16383181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phototherapy in ABO hemolytic disease of the newborn infant.
    Kaplan E; Herz F; Scheye E; Robinson LD
    J Pediatr; 1971 Dec; 79(6):911-4. PubMed ID: 5132303
    [No Abstract]   [Full Text] [Related]  

  • 12. [Meta analysis of the effect of immunoglobulin infusion on neonatal isoimmune hemolytic disease caused by blood group incompatibility].
    Li ZH; Wang J; Chen C
    Zhonghua Er Ke Za Zhi; 2010 Sep; 48(9):656-60. PubMed ID: 21092522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperbilirubinemia due to minor blood group (anti-E) incompatibility in a newborn: a case report.
    Özcan M; Sevinç S; Erkan VB; Yurdugül Y; Sarıcı SÜ
    Turk Pediatri Ars; 2017 Sep; 52(3):162-164. PubMed ID: 29062250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose intravenous immune globulin therapy for hyperbilirubinemia caused by Rh hemolytic disease.
    Rübo J; Albrecht K; Lasch P; Laufkötter E; Leititis J; Marsan D; Niemeyer B; Roesler J; Roll C; Roth B
    J Pediatr; 1992 Jul; 121(1):93-7. PubMed ID: 1306646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phototherapy of jaundice in newborn infant. I. ABO blood group incompatibility.
    Sisson TR; Kendall N; Glauser SC; Knutson S; Bunyaviroch E
    J Pediatr; 1971 Dec; 79(6):904-10. PubMed ID: 5132302
    [No Abstract]   [Full Text] [Related]  

  • 16. Intravenous immunoglobulin in ABO and Rh hemolytic diseases of newborn.
    Nasseri F; Mamouri GA; Babaei H
    Saudi Med J; 2006 Dec; 27(12):1827-30. PubMed ID: 17143357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive Direct Antiglobulin Test: Is It a Risk Factor for Significant Hyperbilirubinemia in Neonates with ABO Incompatibility?
    Ercin S; Coskun Y; Kayas K; Kavas N; Gursoy T
    Am J Perinatol; 2024 Mar; 41(4):505-510. PubMed ID: 34847590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carboxyhemoglobin levels in neonatal immune hemolytic jaundice treated with intravenous gammaglobulin.
    Ergaz Z; Gross D; Bar-Oz B; Peleg O; Arad I
    Vox Sang; 1995; 69(2):95-9. PubMed ID: 8585207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy and safety of intravenous immunoglobulins in the management of neonatal hyperbilirubinemia due to ABO incompatibility: a meta-analysis].
    Cortey A; Elzaabi M; Waegemans T; Roch B; Aujard Y
    Arch Pediatr; 2014 Sep; 21(9):976-83. PubMed ID: 25125032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose intravenous immunoglobulin therapy in neonatal immune haemolytic jaundice.
    Alpay F; Sarici SU; Okutan V; Erdem G; Ozcan O; Gökçay E
    Acta Paediatr; 1999 Feb; 88(2):216-9. PubMed ID: 10102158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.